Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Berlin - Delayed Quote EUR

Terns Pharmaceuticals Inc (430.BE)

Compare
3.6000
+0.0400
+(1.12%)
As of 12:12:07 PM GMT+1. Market Open.

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

37.4

Severe

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
MVR0.SG Medivir AB 38 -- -- --
08D.F Mirum Pharmaceuticals Inc. R 38 -- -- --
430.BE Terns Pharmaceuticals Inc. R 37 -- -- --
9PT.SG 9PT.SG,0P0001K2D7,0 37 -- -- --
8C5.F Coherus Biosciences Inc. R 37 -- -- --

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 2/2025
430.BE
Category Average
N/A None Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No

Related Tickers